Azurity Pharmaceuticals, Inc. et al v. Hetero Labs Limited et al
| Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited |
| Hetero Labs Limited, Hetero Labs Limited Unit-V and Hetero USA Inc. |
| 1:2024cv00396 |
| March 28, 2024 |
| US District Court for the District of Delaware |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on March 28, 2024. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 8 Summons Issued as to Hetero Labs Limited on 3/28/2024; Hetero Labs Limited Unit-V on 3/28/2024; Hetero USA Inc. on 3/28/2024. (Attachments: #1 Summons Issued Hetero USA Inc, #2 Summons Issued Hetero Labs Limited) (vfm) |
| Filing 7 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Master Trust Bank of Japan, Ltd. for Takeda Pharmaceutical Company Limited filed by Takeda Pharmaceutical Company Limited. (vfm) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent CutisPharma Intermediate Holdings, Inc. for Azurity Pharmaceuticals, Inc. filed by Azurity Pharmaceuticals, Inc.. (vfm) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Arbor Pharmaceuticals, Inc., Other Affiliate Azurity Pharmaceuticals, Inc. for Arbor Pharmaceuticals, LLC filed by Arbor Pharmaceuticals, LLC. (vfm) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,066,936. (vfm) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 02/16/2024. Date of Expiration of Patent: 03/26/2028.Thirty Month Stay Deadline: 8/16/2026. (vfm) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (vfm) |
| Filing 1 COMPLAINT for ANDA/PATENT INFRINGEMENT filed against Hetero Labs Limited, Hetero Labs Limited Unit-V, Hetero USA Inc. ( Filing fee $ 405, receipt number ADEDC-4372453.) - filed by Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Attachments: #1 Exhibit A, #2 Civil Cover Sheet) (vfm) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
